Wrinkle Clinical Trial
Official title:
A Prospective, Multicenter, Single Arm Clinical Study Evaluating the Use of the Renuvion Dermal System for Dermal Resurfacing
NCT number | NCT04185909 |
Other study ID # | VP-1909 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 30, 2019 |
Est. completion date | May 13, 2021 |
Verified date | June 2022 |
Source | Apyx Medical |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a multi-center, single arm, evaluator-blind prospective study of up to 55 study subjects who are seeking a procedure to reduce the appearance of wrinkles and rhytides.
Status | Completed |
Enrollment | 55 |
Est. completion date | May 13, 2021 |
Est. primary completion date | March 23, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years and older |
Eligibility | Inclusion Criteria: 1. Male or female subjects =30 years of age. 2. Subject is seeking improvement of facial appearance by reducing facial wrinkles and rhytides. 3. Subject with a facial wrinkle score rating of at least 4 on the FWS. 4. Subject with a Fitzpatrick Skin Scale score =III. 5. Subjects who are willing and able to take protocol allowed medications prescribed at investigator discretion which may include Keflex or Z-pack as an antibiotic, Acyclovir or Valtrex as an antiviral, Diflucan as an antifungal, Ativan or Valium for anxiety during treatment, Norco or Ultram for pain control during or post-procedure, Gabapentin, Tylenol with Codeine or NSAIDS for post-procedure pain control, and/or Antihistamines for itching during healing. 6. Subjects who are willing to have polycarbonate eye shields placed for study treatment. 7. Subject is willing and able to provide written informed consent. 8. Subject is willing and able to comply with protocol requirements, including obtaining study-required images/photos and assessments, post-care instructions, and returning for follow-up visits. 9. Subject is willing to maintain baseline skin care regimen during study participation with the exception when protocol specified ointments, moisturizers, and cleansers are required during healing stage (through approximately the 30-day follow-up). Sunblock is required throughout the study starting on approximately day 10. 10. Subject is willing to release rights to study Sponsor for the use of the photos, including in potential publication. 11. Subject is willing to abstain from other facial cosmetic procedures through the 6-month follow-up visit; examples include, but are not limited to, laser or chemical re-surfacing, dermabrasion, neuromodulator and/or filler injections, aesthetic facial surgery, etc. Exclusion Criteria: 1. Subject with a Fitzpatrick Skin Scale score =IV. 2. Subject is pregnant or lactating. 3. Active HSV-1 or diabetes mellitus. 4. Active cut, wound, or infection on the skin of the face. 5. Subject has used, within 30 days prior to screening or plans to use during study participation, Accutane, Retinol, or any medication that can cause dermal hypersensitivity. 6. Subject has used, within 10 days prior to study treatment, aspirin or NSAIDs. 7. Subject has a history of autoimmune disease (excluding Hashimoto's thyroiditis). 8. Subject with a known bleeding disorder or who is on blood thinning medication that may be at risk for bleeding. 9. Subject has a known adverse reaction to lidocaine and/or epinephrine. 10. Subjects with active skin disease of the facial area or known connective tissue disease. 11. Subjects with known susceptibility to keloid formation or hypertrophic scarring. 12. Subjects with present cancerous or pre-cancerous lesions in the area to be treated. 13. Subject who, for any reason, suspects that they will not be able to complete the prescribed follow-up assessment(s). 14. Subject has had concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety and effectiveness of the study treatment method. 15. Subject is not willing to release rights to study Sponsor for the use of the photos, including in potential publication. 16. Subject is enrolled in another investigational (drug or device) clinical trial that can interfere with this study's assessments. 17. Subject has undergone a facelift procedure within 12 months prior to the screening visit. 18. Subject has received IPL, microneedling, or chemical peels within 3 months prior to the screening visit. 19. Subject has received microneedling with RF or any facial treatment with an energy-based device within 6 months prior to the screening visit. 20. Subject has received facial injections with BOTOX® or other toxins within 6 months prior to the screening visit. 21. Subject has received hyaluronic acid or calcium hydroxylapatite fillers within 4 months prior to the screening visit. 22. Subject who is a family member or employee of the investigator or sponsor. 23. Participation in any other investigational study within 30 days prior to consent. 24. Subject who, in the opinion of the investigator, is not an appropriate candidate for the study. |
Country | Name | City | State |
---|---|---|---|
United States | Contemporary Plastic Surgery | Jacksonville | Florida |
United States | Aesthetic Revolution Las Vegas | Las Vegas | Nevada |
United States | Holcomb-Kreithen Plastic Surgery and MedSpa, PLLC | Sarasota | Florida |
United States | Michael Lin, MD | Sherman Oaks | California |
Lead Sponsor | Collaborator |
---|---|
Apyx Medical |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Independent Photographic Reviewer Masked Assessment | At least 2 out of 3 blinded Independent Photographic Reviewers (IPRs) correctly identify the 90-day image of a subject from the pair of baseline and 90-day images. | 90-day | |
Other | Investigator Fitzpatrick Wrinkle and Elastosis Scale | Magnitude of improvement measured by the mean change in FWS from baseline, 90-day, 180-day visit as determined by Investigators. Scale ranges from 1 (no wrinkles) to 9 (most wrinkles). | Baseline, 90-day Change, 180-day Change | |
Other | Subject Global Aesthetic Improvement Scale | Subject rated GAIS: Very much improved, much improved, improved, no change, worse, much worse, very much worse | 90-day | |
Other | Investigator Global Aesthetic Improvement Scale | Investigator rated GAIS: Very much improved, much improved, improved, no change, worse, much worse, very much worse | 90-day | |
Other | Patient Satisfaction Questionnaire | 5 questions pertaining to satisfaction with results, would you recommend to a friend, would you have the procedure done again, any changes noticed, and any improvement in quality of life. | 90-day | |
Other | Pain and Discomfort | Evaluation of the change in pain and discomfort after treatment (baseline, within 60 minutes following the procedure) as reported by the subject on a visual analog scale (VAS)experienced in the period up to the 10-day follow-up visit. Any pain or discomfort will be recorded daily by each participant in a diary using an 11-point Visual Analogue Scale (VAS) where 0 is no pain and 10 is most pain. | Baseline to Day 10 | |
Other | Percentage of Subjects With Achievement of Re-Epithelialization | Achievement of re-epithelialization by facial zone and across all facial zones as reported by the investigator. | 10-day, 30-day, 90-day | |
Other | Comfortable in Public | Mean duration until study subject feels comfortable going in public after treatment as reported by the study subject. Willing to go out in public by the 10-day visit. | 10-day | |
Primary | Independent Photo Reviewer Fitzpatrick Wrinkle and Elastosis Scale (FWS) | The FWS is a clinically validated assessment tool used to assess skin wrinkle severity and elastosis on a scale from 1 through 9, where the lower the value, the better the outcome. Three Independent Photographic Reviewers were blinded to the study subject's visit (Day 90 follow-up visit) and performed photographic assessments of each subject's wrinkle depth in the treated zones. | 90-day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05098912 -
Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction
|
N/A | |
Completed |
NCT05271136 -
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
|
N/A | |
Completed |
NCT05096247 -
Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device
|
N/A | |
Completed |
NCT05097157 -
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
|
N/A | |
Completed |
NCT04128046 -
The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation
|
N/A | |
Active, not recruiting |
NCT04727099 -
Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™
|
N/A | |
Active, not recruiting |
NCT06140628 -
A 28-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Not yet recruiting |
NCT05524779 -
BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement
|
N/A | |
Completed |
NCT05514782 -
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
|
N/A | |
Completed |
NCT06123572 -
A Clinical Study to Assess the Safety and Effectiveness of Anti-Ageing and Skin Brightening Gel
|
N/A | |
Completed |
NCT04911374 -
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
|
N/A | |
Recruiting |
NCT04989361 -
Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles.
|
N/A | |
Recruiting |
NCT04540900 -
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
|
Phase 1 | |
Recruiting |
NCT06202274 -
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
|
N/A | |
Recruiting |
NCT06074276 -
The Effects of Almond on Facial Skin Collagen and Wrinkles
|
N/A | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Active, not recruiting |
NCT06219278 -
A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles
|
N/A | |
Active, not recruiting |
NCT06192550 -
Functional Usability and Feasibility Testing of the Profound Matrix™ System
|
N/A | |
Completed |
NCT04650620 -
Study to Evaluate the Performance and Safety of the Medical Device Plenhyage®
|
N/A | |
Completed |
NCT03729700 -
The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome
|
N/A |